Physician profile
Anthony Allen
NPI 1457441222
$1,306.38
in general payments reported to CMS, 2019-2025
19 companies · $15.06 in 2025
The $15.06 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $312 · 2022: $446 · 2023: $444 · 2024: $89.55 · 2025: $15.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $477.82 | 2021-2023 | Ozempic, Rybelsus |
| Abbott Laboratories | $199.05 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2, Freestyle Freedom Lite |
| Xeris Pharmaceuticals, INC. | $107.13 | 2022-2023 | Gvoke Hypopen |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.74 | 2021 | |
| Abbvie INC. | $70.09 | 2022-2025 | |
| Glaxosmithkline, LLC. | $60.51 | 2021-2023 | Trelegy Ellipta |
| Horizon Therapeutics Plc | $47.03 | 2022-2023 | Krystexxa |
| Lilly USA, LLC | $33.77 | 2021-2023 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $33.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $31.86 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $25.84 | 2023 | |
| Exact Sciences Corporation | $24.33 | 2023 | Cologuard Collection Kit |
| Boston Scientific Corporation | $24.21 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.63 | 2022 | |
| Vivus LLC | $16.04 | 2023 | Qsymia |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Specialty L.P. | $15.52 | 2022 | |
| Pfizer INC. | $15.48 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.50 | 2023 | Farxiga |
| Merck Sharp & Dohme LLC | $13.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.